Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers ...
CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs. | ...
Humana (HUM) has been drawing fresh attention as investors reassess the health insurer’s recent share performance, with the ...
Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management ...
Humana is ramping up its focus on primary care. The insurer plans to shell out between $450 million and $550 million to buy the first group of senior-focused primary care centers it built through a ...
Zacks Investment Research on MSN
Why Humana deserves patience now: Too early to buy, too risky to sell
Humana Inc. HUM has tested investor conviction over the past year as rising medical costs, reimbursement uncertainty, and ...
Humana's margins have declined due to rising policy benefits, high medical loss ratios, and increased utilization ...
Humana and Mercy partner to streamline healthcare for seniors, emphasizing ease of access and whole-person care to address ...
Humana announced it was bringing Dintenfass on board to lead enterprise growth five minutes after releasing a growth outlook for 2024 that significantly undershot investors’ expectations. In the newly ...
Barclays raised the firm’s price target on Humana (HUM) to $245 from $234 and keeps an Equal Weight rating on the shares. The firm sees managed ...
Health insurer Humana will begin contracting with healthcare providers to offer coordinated care for patients who are beneficiaries of original Medicare. Humana is known for offering Medicare ...
Humana said it is investing $100 million in the in-home primary care company, Heal, to bring in-person physician “house calls and one-touch medicine” to seniors in its Medicare Advantage plans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results